We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$2.28B
AUM Growth
+$25.9M
Cap. Flow
-$48.9M
Cap. Flow %
-2.15%
Top 10 Hldgs %
56.73%
Holding
317
New
10
Increased
21
Reduced
98
Closed
14

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$38M
2
MELI icon
Mercado Libre
MELI
+$16.2M
3
GE icon
GE Aerospace
GE
+$12.8M
4
GEV icon
GE Vernova
GEV
+$5.35M
5
ARES icon
Ares Management
ARES
+$4.75M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$38.3M
2
BA icon
Boeing
BA
+$22.7M
3
LRCX icon
Lam Research
LRCX
+$9.55M
4
AAPL icon
Apple
AAPL
+$9.24M
5
FICO icon
Fair Isaac
FICO
+$6.35M

Sector Composition

Rank Sector Weight
1 Technology 45.87%
2 Consumer Discretionary 13.06%
3 Healthcare 11.97%
4 Communication Services 10.82%
5 Industrials 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
101
Merck
MRK
$322B
$3.11M 0.14%
27,174
-2,900
-10% -$345K
IBM icon
102
IBM
IBM
$211B
$3.07M 0.13%
13,905
-1,458
-9% -$286K
PODD icon
103
Insulet
PODD
$11.5B
$2.97M 0.13%
12,769
-90
-0.7% -$18.5K
LPLA icon
104
LPL Financial
LPLA
$28.3B
$2.97M 0.13%
12,746
BSY icon
105
Bentley Systems
BSY
$10.8B
$2.85M 0.12%
56,034
ZS icon
106
Zscaler
ZS
$24.5B
$2.82M 0.12%
16,522
CI icon
107
Cigna
CI
$73.7B
$2.8M 0.12%
8,084
-1,033
-11% -$356K
XYL icon
108
Xylem
XYL
$27.3B
$2.62M 0.12%
19,414
CHDN icon
109
Churchill Downs
CHDN
$5.88B
$2.62M 0.11%
19,345
+4,905
+34% +$678K
TSLA icon
110
Tesla
TSLA
$1.23T
$2.58M 0.11%
9,874
-1,340
-12% -$306K
PGR icon
111
Progressive
PGR
$123B
$2.54M 0.11%
10,024
-1,275
-11% -$296K
NBIX icon
112
Neurocrine Biosciences
NBIX
$16.8B
$2.52M 0.11%
21,833
RACE icon
113
Ferrari
RACE
$69.2B
$2.45M 0.11%
5,202
HCA icon
114
HCA Healthcare
HCA
$87.2B
$2.35M 0.1%
5,782
-740
-11% -$271K
LYV icon
115
Live Nation Entertainment
LYV
$40.6B
$2.3M 0.1%
21,035
GTLS
116
DELISTED
Chart Industries
GTLS
$2.24M 0.1%
18,068
ULTA icon
117
Ulta Beauty
ULTA
$22B
$2.22M 0.1%
5,712
FN icon
118
Fabrinet
FN
$15.6B
$2.22M 0.1%
9,397
+2,826
+43% +$654K
VEEV icon
119
Veeva Systems
VEEV
$33.1B
$2.18M 0.1%
10,373
GEHC icon
120
GE HealthCare
GEHC
$30.7B
$1.99M 0.09%
21,221
-2,668
-11% -$224K
SYK icon
121
Stryker
SYK
$125B
$1.99M 0.09%
5,490
-702
-11% -$242K
CME icon
122
CME Group
CME
$96.3B
$1.89M 0.08%
8,586
-1,028
-11% -$213K
ITW icon
123
Illinois Tool Works
ITW
$82.6B
$1.87M 0.08%
7,112
-869
-11% -$214K
DE icon
124
Deere & Co
DE
$160B
$1.86M 0.08%
4,448
-113
-2% -$42.6K
HOOD icon
125
Robinhood
HOOD
$77.8B
$1.82M 0.08%
77,690
+32,084
+70% +$676K

Similar funds

Silvant Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Silvant Capital Management held 317 positions worth $2.28B, up 1.1% from $2.25B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Silvant Capital Management's Q3 2024 filing shows 10 new, 21 increased, 98 reduced and 14 closed positions. Its largest new stake was Ares Management: 32,755 shares worth $5.1M. The largest sale was Edwards Lifesciences, an estimated $38.3M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Silvant Capital Management's largest Q3 2024 buy was Ares Management: 32,755 shares worth $5.1M.
  • Silvant Capital Management added most to Netflix in Q3 2024, an estimated $38M increase.
  • Silvant Capital Management's biggest Q3 2024 reduction was Boeing, cutting an estimated $22.7M.
  • Silvant Capital Management fully exited Edwards Lifesciences in Q3 2024, selling an estimated $38.3M.
  • Silvant Capital Management's ten largest holdings make up 57% of its $2.28B portfolio in Q3 2024.
  • Silvant Capital Management opened 10 new positions and closed 14 in Q3 2024.
  • Silvant Capital Management's portfolio value rose 1.1% quarter-over-quarter to $2.28B.

Based on Silvant Capital Management's 13F filing for Q3 2024, filed 29 Oct 2024.